An attempt to improve antipsychotic medication adherence by feedback of medication possession ratio scores to prescribers

Population Health Management

Volumn 13, Issue 5, 2010, Pages 269-274

  Patel, Urvashi B ^a   Ni, Quanhong ^a   Clayton, Carol ^a   Lam, Peter ^b   Parks, Joseph ^c  

^a Caremanagement Technologies   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; ZIPRASIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL PERSONNEL; MENTAL DISEASE; PATIENT COMPLIANCE; PRESCRIPTION; REMINDER SYSTEM; STATISTICAL ANALYSIS;

ANTIPSYCHOTIC AGENTS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INSURANCE CLAIM REPORTING; LINEAR MODELS; MALE; MEDICAID; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; MISSOURI; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PSYCHOTIC DISORDERS; QUALITY OF HEALTH CARE; REGRESSION ANALYSIS; UNITED STATES;

EID: 77957727861     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2009.0053     Document Type: Article

References (40)

1. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2: CD000011.
2. Faught RE, Weiner JR, Guerin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009;50:5013-509.
3. Thier SL, Yu-Isenberg KS, Leas BF, et al. In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines. Manag Care. 2008;17:48-52, 55-57.
4. Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts SR, Johnson AL. Patient compliance with antihyperten-sive regimens. Patient Couns Health Educ. 1978;1st Quart: 18-21.
5. Van-Wanghe P, Dequeker J. Compliance and long-term effect of azathioprine in 65 rheumatoid arthritis cases. Ann Rheum Dis. 1982;41(suppl 1):40-43.
6. Strunk RC, Bender B, Young DA, et al. Predictors of poor adherence in a pediatric asthma clinical trial. J Allergy Clin Immunol. 2002;110:596-602.
7. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcome: A meta-analysis. Med Care. 2002;40:794-811.
8. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55:886-891.
9. Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication adherence and hospitali-zation risk in schizophrenia. J Clin Psychiatr. 2008;69:47-53.
10. Morken G, Widen JH, Grawe RW. Non-adherence to anti-psychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiat. 2008;8:32.
11. Lage MJ, Hassan MK. The relationship between antipsy-chotic medication adherence and patient outcome among individuals diagnosed with bipolar disorder: A retrospective study. Ann Gen Psychiatr. 2009;8:7.
12. Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther. 2007;30:1358-1374.
13. Colom F, Vieta E, Tacchi MJ, Sanchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7(suppl 5):24-31.
14. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
15. Herings R M C, Erkens JA. Increased suicide attempt rates among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Saf. 2003;12:433-434.
16. Ascher-Svanum H, Faries DE, Zhu B, Ernst F, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 2006;67:453-460.
17. st Annual Meeting; December 8-12, 2002; San Juan, Puerto Rico.
18. McClellan TA, Cowan G. Use of antipsychotic and antide-pressant drugs by chronically ill patients. Am J Psychiatry. 1970;126:1771-1773.
19. Byerly MJ, Thompson AT, Carmody T, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv. 2007;58:844-847.
20. Butler JA, Peveler RC, Roderick P, Horne R, Mason JC. Measuring compliance with drug regimens after renal transplantation: Comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004;77:786-789.
21. Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA; Comparison of Atypicals in First Episode study group. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffec-tive disorder: A randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry. 2008;69:106-113.
22. Misdrahi D, Verdoux H, Lancon C, Bayle F. The 4-Point ordinal Alliance Self-report: A self-report questionnaire for assessing therapeutic relationships in routine mental health. Compr Psychiatry. 2009;50:181-185.
23. Masand PS, Narasimhan M. Improving adherence to antipsy-chotic pharmacotherapy. Curr Clin Pharmacol. 2006;1:47-56.
24. Sajatovic M, Ignacio RV, West JA, et al. Predictors of non-adherence among individuals with bipolar disorder receiving treatment in community mental health clinic. Compr Psychiatry. 2009;50:100-107.
25. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159:1653-1664.
26. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: Review of recent literatures. J Clin Psychopharmacol. 2003;23:389-399.
27. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psy-chiatr Serv. 2004;55:264-269.
28. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.
29. Dezii CM. Persistence with drug therapy: A practical approach using administrative claims data. Manag Care. 2001;10:43-45.
30. Valenstein M, Copeland LA, Blow FC, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002;40:630-639.
31. DMAA: The Care Continuum Alliance. Outcomes Guidelines Report Volume III. Washington, DC; DMAA: The Care Continuum Alliance; 2008:56.
32. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: A review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15:34-44.
33. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: A randomised controlled trial in schizophrenia. BMJ. 2003;327:834.
34. Siddle K, Kingdon D. The management of schizophrenia: cognitive behaviour therapy. Br J Community Nursing. 2000;5:20-25.
35. Brunenberg DE, Wetzels GE, Nelemans PJ, et al. Cost effectiveness of an adherence-improving programme in hypertensive patients. Pharmacoeconomics. 2007;25:239-251.
36. Uttaro T, Finnerty M, White T, Gaylor R, Shindelman L. Reduction of concurrent antipsychotic prescribing practices through the use of PSYCKES. Adm Policy Ment Health. 2007;34:57-61.
37. Kunz R, Wegscheider K, Guyatt G, et al. Impact of short evidence summaries in discharge letters on adherence of practitioners to discharge medication. A cluster-randomised controlled trials. Qual Safe Health Care. 2007;16:456-461.
38. Parks J, Surles R. Using best practices to manage psychiatric medications under Medicaid. Psychiatr Serv. 2004;55:1227-1229.
39. Ostini R, Hegney D, Jackson C, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43:502-513.
40. Clayton CD, Veach I, Macfadden W, Haskins J, Docherty JP, Lindenmayer JP. Assessment of clinician awareness of non-adherence using a new structured rating scale. J Psychiatr Pract 2010;16:164-169.